Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹84.2 Cr -9% -18.7% -50.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹8,581.9 Cr -7.3% -17.8% 10.9% Stock Analytics
KIRI INDUSTRIES ₹3,183.0 Cr -3.4% -10.6% 37.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,600.7 Cr -5.6% -8.1% -28.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,260.7 Cr -7.4% -9.1% 51.5% Stock Analytics
BODAL CHEMICALS ₹753.4 Cr -2% -3.6% -21% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-9%

-18.7%

-50.2%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses